Dr. Andrew Muir: Investment Director & Fund Principal

Dr. Andrew Muir

Dr. Andrew Muir joined Midven in 2004. He is a Director of the Company and Fund Principal of the Rainbow Seed Fund and the Early Advantage fund.

After an initial scientific career at Zeneca he went on to roles in research and business development at the medical device company Biocompatibles and then Vice President of Technology for a US start-up in disinfection of medical equipment.

He started his career in VC with the £4m per annum Invention and Innovation seed capital fund at NESTA (the National Endowment for Science Technology and the Arts). He has a degree and a PhD in Chemistry from the University of Oxford.

Andrew combines a strong scientific and technical grounding with a real commercial pragmatism developed from his operational roles.

Telephone 0121 710 1990

“Development and commercialisation of new technologies is key to the UK retaining its global competitiveness.”

Dr. Andrew Muir

Associated Companies

Relevant News

Rainbow Seed Fund Backs Pireta

A Smart Textiles Technology Developed at the National Physical Laboratory Rainbow Seed Fund, an early-stage…

read more

Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m

Collaboration to generate tumor targeting drug conjugates and immuno-oncology therapeutics Crescendo Biologics Limited (Crescendo), the…

read more

Rainbow Seed Fund Backs New STFC Spin Out MIRICO

Spin out from UK publicly-funded research develops novel laser spectroscopy for environmental, medical diagnosis and…

read more

Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property

Cambridge, UK: 2 February 2016 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer…

read more

Oxford Space Systems Secures £1.2m Investment

Oxford Space Systems (OSS) has successfully secured £1.2m in its second round fund raise from…

read more

Case Studies

Case Study - Cobalt Light Systems

Insight From Light Cobalt Light Systems develops innovative instruments and technologies for non-invasive, rapid analysis…

read more

Case Study - Oxsensis

Summary Oxsensis is pioneering a “new breed” of highly accurate, highly stable optical sensors. Using…

read more

Blog

A Discussion with Dr Andrew Muir Midven Director

Andrew Muir, PhD, is a director at Midven, and leads the Rainbow Seed Fund team.…

read more

The Rainbow Seed Fund: Kickstarting Technology

Creating a new technology company is an exciting time. It is an opportunity to get…

read more

Other Team Members